warnings
Warnings • In case of overdose, get medical help or contact a Poison Control Center right away. • If pregnant or breast-feeding, ask a healthcare professional before use. • Keep out of reach of children.
ReHydration
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- ReHydration
- Generic name
- ADENOSINUM CYCLOPHOSPHORICUM, COFFEA CRUDA, GLANDULA SUPRARENALIS SUIS, HYPOTHALAMUS, KALI PHOS, NAT MUR, SARSAPARILLA, SILICEA, TARAXACUM, THYROIDINUM
- Manufacturer
- Energetix Corporation
- Product type
- HUMAN OTC DRUG
- SPL set ID
- 9b532a31-530a-44f9-843f-f395a3e460b8
- SPL ID
- 462bd451-0960-cd77-e063-6394a90a9d4d
- Version
- 4
- Effective date
- 2025-12-17
- Source export date
- 2026-09-28
- Source partition
- 12
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/663999d0fe1757c1e2cd13a4799d76d875f663e0bc57701092264ebe7febfc18/drug-label-0012-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 06:27:55
| Harmonized routes |
|---|
| ORAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| brand name | ReHydration | openfda.brand_name | |
| generic name | ADENOSINUM CYCLOPHOSPHORICUM, COFFEA CRUDA, GLANDULA SUPRARENALIS SUIS, HYPOTHALAMUS, KALI PHOS, NAT MUR, SARSAPARILLA, SILICEA, TARAXACUM, THYROIDINUM | openfda.generic_name | |
| manufacturer name | Energetix Corporation | openfda.manufacturer_name | |
| ndc | package | 64578-0175-1 | openfda.package_ndc |
| ndc | product | 64578-0175 | openfda.product_ndc |
| ndc11 | package | 64578017501 | derived:openfda.package_ndc |
| spl id | 462bd451-0960-cd77-e063-6394a90a9d4d | id | |
| spl set id | 9b532a31-530a-44f9-843f-f395a3e460b8 | set_id | |
| unii | CI71S98N1Z | openfda.unii | |
| unii | 3SW678MX72 | openfda.unii | |
| unii | 9DE5YCO0RU | openfda.unii | |
| unii | 0B4FDL9I6P | openfda.unii | |
| unii | 2H1576D5WG | openfda.unii | |
| unii | ETJ7Z6XBU4 | openfda.unii | |
| unii | 451W47IQ8X | openfda.unii | |
| unii | S6G2NLH4Y7 | openfda.unii | |
| unii | 398IYQ16YV | openfda.unii | |
| unii | E0399OZS9N | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.